Combination BRAF/MEK Inhibitor Targeted Therapy and Immunotherapy (atezolizumab + vemurafenib + cobimetinib) for Metastatic Cutaneous Melanoma: Clinical Case by V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, V. S. Chalov, N. I. Sultanbaeva, I. A. Menshikova

Get full text

Predictors of Multiple Primary Malignancies: Literature Review by A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, A. A. Izmailov, I. A. Menshikova, N. I. Sultanbaeva

Get full text

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review) by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, O. N. Lipatov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova

Get full text